The question of whether a sexual desire is a human right is one of the issues being raised by supporters of a pill that likely will make women feel it before an advisory committee to the Food and Drug Administration (FDA) today. The campaign for passage of measures that would make the pill available is partially rooted in traditional thoughts of women’s equality; some women believe the FDA is engaged in gender bias because the agency has regularly approved pills such as Viagra, and at least 25 other drugs, for men and none for women. A petition is circulating that states, “Women have waited long enough”, and has gathered more than 40,000 signatures. The drug is called “flibanserin”, and it has been rejected by the FDA twice based upon contentions that the game is not worth the candle since the probative benefits of the pill are outweighed by the prejudicial side effects, such as dizziness and nausea. The FDA flatly rejects the contention that they are discriminating against women, and some women’s organization have not jumped in to support the movement. The entire issue has been delayed over the past 11 years or so because drug companies are profit driven and tend to slow down research efforts in areas where FDA approval is questionable. The New York Times covered this story and included a video that has been going around that makes a mockery of the alleged discriminatory practice. If you watch the video, you will find links to some rather strange and funny videos about spoof commercials that were allegedly banned.
UPDATE: 6/4/15 @10.00 p.m.:
A federal advisory panel recommended approval of what would become the first drug to treat a lack of sexual desire in women. The committee voted 18-6 to recommend that the FDA approve flibanserin, a drug designed to boost the sexual desire of women who are otherwise healthy. The FDA usually follows the recommendations of its advisory committees. A decision from the FDA is expected later this summer.